TargetMol

Diclofensine hydrochloride

Product Code:
 
TAR-T7745
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7745-5mg5mg£108.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7745-10mg10mg£132.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7745-25mg25mg£195.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7745-50mg50mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7745-100mg100mg£414.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7745-200mg200mg£551.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Diclofensine hydrochloride is a Novel Antidepressant, on Peripheral Adrenergic Function
CAS:
34041-84-4
Formula:
C17H18Cl3NO
Molecular Weight:
358.69
Pathway:
GPCR/G Protein; ; Neuroscience
Purity:
0.98
SMILES:
Cl.COc1ccc2C(CN(C)Cc2c1)c1ccc(Cl)c(Cl)c1
Target:
Dopamine Receptor

References

Renzo G D , Amoroso S , Taglialatela M , et al. Pure uptake blockers of dopamine can reduce prolactin secretion: Studies with diclofensine[J]. Life Sciences, 1988, 42(21):2161-2169. S Gasi?, Korn A , Eichler H G . Effect of diclofensine, a novel antidepressant, on peripheral adrenergic function[J]. Clinical Pharmacology & Therapeutics, 1986, 39.